AIKON Health B.V., in collaboration with TNO, Unitron Systems B.V., and Datacation B.V., has successfully secured funding from the OPZuid 2021–2027 program to develop an innovative wearable monitoring device designed for heart failure patients. The device will allow continuous, remote tracking of vital signs, providing real-time data to healthcare professionals, improving patient care, and helping reduce hospital admissions.

​

The HeartLinQ project has a total budget of €2.66 million, including €872,000 in private investment, and is organized into six core work packages: management, promotion, development, testing, validation, and data analysis. The initiative is a collaborative effort between research institutions and innovative SMEs, aimed at driving healthcare technology advancements in the Netherlands.

​

The grant enables to advance cutting-edge remote monitoring technology. “HeartLinQ has the potential to transform care for heart failure patients, enhancing their quality of life while easing the burden on hospitals.”

 

The project will undergo rigorous testing and clinical validation to ensure that the device meets high standards for reliability, accuracy, and patient safety. The consortium is committed to generating practical, real-world results that can be applied widely in patient care.

 

Outcomes from HeartLinQ are expected to contribute significantly to ongoing European efforts in advancing remote patient monitoring and digital health solutions.

​

For more information, contact Kevin Witteveen at Stimulus Program Management.